Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT07648693
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 240 participants
- Sponsor
- Resonova (Shanghai) Medtech Limited
- Registry
-
NCT07648693
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07648693. Randomized; no masking; primary purpose prevention. Start 2025-10-31 (actual); primary completion 2026-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
- Condition
- Cerebral Vascular Accident (CVA)/Stroke
- Intervention (Device)
- CHORDS® Cerebral Protection System
- Intervention (Device)
- Sentinel Cerebral Protection System
- Lead sponsor
- Resonova (Shanghai) Medtech Limited
Record details
- Record id
cardio:ct-nct07648693- Content hash
dd7d1228fa0aeb2097b3121adad6c7eb7995e8a6ed33175a9c25dcd04cf04b4b